Compare DNTH & QUBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNTH | QUBT |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 2.1B |
| IPO Year | 2018 | 2019 |
| Metric | DNTH | QUBT |
|---|---|---|
| Price | $83.63 | $8.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $121.00 | $17.50 |
| AVG Volume (30 Days) | 670.0K | ★ 12.9M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | $682,000.00 |
| Revenue This Year | N/A | $3,210.56 |
| Revenue Next Year | $29.48 | $51.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 82.84 |
| 52 Week Low | $16.77 | $6.18 |
| 52 Week High | $96.50 | $25.84 |
| Indicator | DNTH | QUBT |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 51.48 |
| Support Level | $33.94 | $7.70 |
| Resistance Level | $88.45 | $9.15 |
| Average True Range (ATR) | 3.83 | 0.65 |
| MACD | -1.66 | 0.06 |
| Stochastic Oscillator | 4.02 | 50.73 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.